Hot Features
Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
SAN DIEGO, Sept. 12 /PRNewswire-FirstCall/ -- Discovery Partners International, Inc. (NASDAQ:DPII) announced today that its stockholders approved the previously announced merger with Infinity...
CAMBRIDGE, Mass., Sept. 11 /PRNewswire/ -- Infinity Pharmaceuticals, Inc. will hold a conference call to discuss the outcome of the proxy vote on the proposed reverse merger between Infinity and...
SAN DIEGO, Sept. 8 /PRNewswire-FirstCall/ -- Discovery Partners International, Inc. (NASDAQ:DPII) today announced that its board of directors has approved a 4-to-1 reverse split of its common...
CAMBRIDGE, Mass., Aug. 28 /PRNewswire/ -- Infinity Pharmaceuticals, Inc. today announced that Discovery Partners International, Inc. (NASDAQ:DPII), or DPI, has filed a supplement to the Proxy...
SAN DIEGO, Aug. 28 /PRNewswire-FirstCall/ -- Discovery Partners International, Inc. (NASDAQ:DPII) today announced that it has filed a supplement to the joint proxy statement/prospectus dated...
- Alliance to Focus on Novel, Targeted Small Molecule Cancer Therapeutics in Two Key Programs - GAITHERSBURG, Md. and CAMBRIDGE, Mass., Aug. 28 /PRNewswire-FirstCall/ -- MedImmune, Inc...
SAN DIEGO, Aug. 9 /PRNewswire-FirstCall/ -- Discovery Partners International, Inc. (NASDAQ:DPII) today announced unaudited financial results for the three and six month periods ended June 30...
CAMBRIDGE, Mass., Aug. 8 /PRNewswire/ -- Infinity Pharmaceuticals, Inc. today announced that the Securities and Exchange Commission (SEC) has declared effective the Form S-4 Registration...
SAN DIEGO, July 27 /PRNewswire-FirstCall/ -- Discovery Partners International, Inc. (NASDAQ:DPII) today announced that the close of business on Tuesday, August 1, 2006, has been set as the...
- Proprietary, water-soluble inhibitor of Heat shock protein 90 (Hsp90), an important target for molecular cancer therapy - CAMBRIDGE, Mass., July 27 /PRNewswire/ -- Infinity Pharmaceuticals...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
